AUTHOR=Liu Dan , Xing Lijie , Wang Hui , Li Ping , Wei Haichen , Li Zengjun 

TITLE=A patient with ALK-positive large B-cell lymphoma benefit from myeloma-like treatment combined with ALK inhibitor lorlatinib

JOURNAL=Frontiers in Hematology

VOLUME=3

YEAR=2024

URL=https://www.frontiersin.org/journals/hematology/articles/10.3389/frhem.2024.1334577

DOI=10.3389/frhem.2024.1334577

ISSN=2813-3935